Late-Breaking Data from Landmark COAPT™ Trial Show Long-Term Benefits of Abbott's MitraClip™ Device

Go back to Late-Breaking Data from Landmark COAPT™ Trial Show Long-Term Benefits of Abbott's MitraClip™ Device
Abbott Laboratories (NYSE: ABT) Delayed: 102.98 +0.37 (0.36%)
Previous Close $102.61    52 Week High $46.38 
Open $102.27    52 Week Low $36.00 
Day High $103.20    P/E 68.65 
Day Low $101.84    EPS $1.50 
Volume 5,018,235